%20and%20Batch%20Production%20Records%20(BPR).png)
Bergabunglah dengan Buletin Kami
Bergabunglah dengan daftar pelanggan kami untuk mendapatkan artikel terkini, update dan penawaran khusus langsung di kotak masuk Anda
India's next export wave will not be won on tariff advantage alone; mutual reco...
Recognition acknowledges his contribution to advancing Indian pharmaceutical ca...
In an exclusive conversation with Sundeep Prabhu, Senior Vice President, Sales ...
Dr Sharvil Patel says the approval expands Zydus’ portfolio of injectable and i...
Amit Agarwal explains how Howden India developed a cancer care policy for emplo...
Prashant Nagre says the NSE listing strengthens Fermenta’s capital market prese...
The deal will take the Nasdaq-listed Lantheus private. Under the agreement, Curi...
The designation is specifically for patients whose tumours demonstrate a KRAS G1...
Dr Rashem Mothilal explains how the registration aims to expand access to immun...
The agreement covers the use of senaparib as a maintenance monotherapy for adult...
The company said existing investors Duquesne Family Office and Bristol Myers Squ...
Launch follows CDSCO marketing authorisation for disease-modifying therapy ind...
IPO comprises an offer for sale by promoters and investor selling shareholder t...
S Swaminathan, CEO, GS1 India explains to Express Pharma the broader benefits o...
India's Foremost Pharma & Biotech Magazine ~ Power, Politics And Pharma The pos...
The partnership is intended to jointly advance methods that address one of the m...
